Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuichi Harada

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Plos One|June 30, 2016
Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351Samuel N Lockhart, Suzanne L Baker, Nobuyuki Okamura, et al.
Alzheimer'S Research & Therapy|February 28, 2014
Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathiesMichelle T Fodero-Tavoletti, Shozo Furumoto, Leanne Taylor, et al.
Annals of Nuclear Medicine|January 7, 2026
Whole-body biodistribution of [<sup>18</sup>F]SMBT-1: a novel PET tracer for monoamine oxidase B imaging in healthy humansBerihu Mesfin, Yui Ishioka, Yoshiki Ichinose, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2014
In vivo evaluation of a novel tau imaging tracer for Alzheimer's diseaseVictor L Villemagne, Shozo Furumoto, Michelle T Fodero-Tavoletti, et al.
Experimental & Molecular Medicine|July 1, 2026
In-depth multimodal validation of <sup>18</sup>F-THK5351 for imaging monoamine oxidase-B-mediated reactive astrogliosis in Alzheimer's and related neurodegenerative diseasesHeejung Chun, Wongu Youn, Hyunkeong Lim, et al.
Alzheimer'S Research & Therapy|April 1, 2017
Monoamine oxidase B inhibitor, selegiline, reduces <sup>18</sup>F-THK5351 uptake in the human brainKok Pin Ng, Tharick A Pascoal, Sulantha Mathotaarachchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2022
Assessing Reactive Astrogliosis with <sup>18</sup>F-SMBT-1 Across the Alzheimer Disease SpectrumVictor L Villemagne, Ryuichi Harada, Vincent Doré, et al.
Acta Neuropathologica Communications|July 1, 2018
Neuroimaging-pathological correlations of [<sup>18</sup>F]THK5351 PET in progressive supranuclear palsyAiko Ishiki, Ryuichi Harada, Hideaki Kai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumVincent Dore, Pierrick Bourgeat, Ryuichi Harada, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumNobuyuki Okamura, Aiko Ishiki, Kotaro Hiraoka, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Plos One|June 30, 2016
Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351Samuel N Lockhart, Suzanne L Baker, Nobuyuki Okamura, et al.
Alzheimer'S Research & Therapy|February 28, 2014
Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathiesMichelle T Fodero-Tavoletti, Shozo Furumoto, Leanne Taylor, et al.
Annals of Nuclear Medicine|January 7, 2026
Whole-body biodistribution of [<sup>18</sup>F]SMBT-1: a novel PET tracer for monoamine oxidase B imaging in healthy humansBerihu Mesfin, Yui Ishioka, Yoshiki Ichinose, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2014
In vivo evaluation of a novel tau imaging tracer for Alzheimer's diseaseVictor L Villemagne, Shozo Furumoto, Michelle T Fodero-Tavoletti, et al.
Experimental & Molecular Medicine|July 1, 2026
In-depth multimodal validation of <sup>18</sup>F-THK5351 for imaging monoamine oxidase-B-mediated reactive astrogliosis in Alzheimer's and related neurodegenerative diseasesHeejung Chun, Wongu Youn, Hyunkeong Lim, et al.
Alzheimer'S Research & Therapy|April 1, 2017
Monoamine oxidase B inhibitor, selegiline, reduces <sup>18</sup>F-THK5351 uptake in the human brainKok Pin Ng, Tharick A Pascoal, Sulantha Mathotaarachchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2022
Assessing Reactive Astrogliosis with <sup>18</sup>F-SMBT-1 Across the Alzheimer Disease SpectrumVictor L Villemagne, Ryuichi Harada, Vincent Doré, et al.
Acta Neuropathologica Communications|July 1, 2018
Neuroimaging-pathological correlations of [<sup>18</sup>F]THK5351 PET in progressive supranuclear palsyAiko Ishiki, Ryuichi Harada, Hideaki Kai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumVincent Dore, Pierrick Bourgeat, Ryuichi Harada, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumNobuyuki Okamura, Aiko Ishiki, Kotaro Hiraoka, et al.
Pageof 9